In 2021, the American Academy of Allergy, Asthma and Immunology (AAAAI), the AXDEV Group, and the Immune Deficiency Foundation (IDF) conducted a survey of over 300 PIDD patients. The purpose of this survey was to identify, from a patient perspective, the…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the seventh of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the sixth of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the fifth of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the fourth of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the third of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the second of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the first of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
